The Power of Rising Earnings Estimates
Stocks with increasing earnings estimates have consistently surpassed the S&P 500 over the years, while those with declining estimates have lagged behind. Enter the Zacks Rank, a tool that simplifies the identification of stocks with shifting earnings estimates, paving the way for profitable trading opportunities.
How the Zacks Rank Works
The Zacks Rank leverages four factors linked to earnings estimates to categorize stocks into five groups, ranging from ‘Strong Buy’ to ‘Strong Sell.’ This classification empowers individual investors to capitalize on trends in earnings estimate revisions, aligning them with the strategies employed by institutional investors.
Examining Success Stories
Let’s delve into the impact of the Zacks Rank on three prominent stocks: NVIDIA (NVDA), The Progressive Corp. (PGR), and HCA Healthcare (HCA).
NVIDIA
NVIDIA’s ascent, fueled by the AI boom, exemplifies the benefits of rising earnings estimate revisions. Achieving a Zacks Rank #1 (Strong Buy) on Feb. 23rd, the stock has surged by nearly 15% since, propelled by exceptional Q4 revenue growth of 409% year-over-year.
Image Source: Zacks Investment Research
The Progressive Corp.
The Progressive Corp. has enjoyed sustained success, with shares climbing 15% following a Zacks Rank #1 (Strong Buy) designation. Growth-oriented investors continue to be drawn to the stock, fueled by robust earnings and sales growth projections.
Image Source: Zacks Investment Research
HCA Healthcare
HCA Healthcare’s positive earnings estimate revisions secured its Zacks Rank #1 (Strong Buy) status on Feb. 9th, propelling the stock to a 9% gain. Noteworthy for its shareholder-friendly practices, HCA boasts a growing dividend with a sustainable payout ratio.
Image Source: Zacks Investment Research
The Bottom Line
Embracing the Zacks Rank has proven to be a winning strategy, with positive earnings estimate revisions acting as a driving force behind market-beating returns. The three highlighted stocks, including NVIDIA, The Progressive Corp., and HCA Healthcare, currently boast a Zacks Rank #1 (Strong Buy), reflecting an upward trajectory in earnings expectations.
